Omalizumab Improves Quality of Life (QoL) in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU) As Assessed By the Dermatology Life Quality Index (DLQI): A Post-Hoc Analysis of Percent Change from Baseline to Week 12
In: The Journal of Allergy and Clinical Immunology, Jg. 135 (2015-02-01), Heft 2, S. AB127
academicJournal
Zugriff:
Titel: |
Omalizumab Improves Quality of Life (QoL) in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU) As Assessed By the Dermatology Life Quality Index (DLQI): A Post-Hoc Analysis of Percent Change from Baseline to Week 12
|
---|---|
Autor/in / Beteiligte Person: | Rosén, Karin ; Khalil, Sam ; Balp, Maria-Magdalena ; Maurer, Marcus |
Zeitschrift: | The Journal of Allergy and Clinical Immunology, Jg. 135 (2015-02-01), Heft 2, S. AB127 |
Veröffentlichung: | 2015 |
Medientyp: | academicJournal |
ISSN: | 0091-6749 (electronic) |
DOI: | 10.1016/j.jaci.2014.12.1348 |
Sonstiges: |
|